U.K. CELL AND GENE THERAPY RESEARCH CHALLENGES MARKET ANALYSIS

U.K. Cell and Gene Therapy Research Challenges Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), and by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2022
Code : CMI4889
Pages :140
Formats :
Excel and PDF
Industry : Biotechnology

U.K. Cell and Gene Therapy Research Challenges MarketSize and Trends

The U.K. cell and gene therapy research challenges market is estimated to be valued at US$ 848 million in 2021 and is expected to exhibit a CAGR of 23.6% over the forecast period (2021-2028).

The increasing product launches and approvals are expected to drive the market growth over the forecast period.

Figure 1. U.K. Cell and Gene Therapy Research Challenges Market Share (%), By Therapy Type, 2021

The increasing adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions by key players in order to strengthen their position in the U.K. market is expected to drive the market growth over the forecast period.

Figure 2. U.K. Cell and Gene Therapy Research Challenges Market Share (%), By Indication, 2021